Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
NAD+ boosters
$422 Billion Industry Just Got Hit With a Cancer Bombshell
Anti-aging pills are a booming business, but new research suggests popular NAD+ boosters might accelerate tumor growth. Is eternal youth worth the cancer risk?
